“Leading Nanotechnologies” venture fund finances a project

“Leading Nanotechnologies” venture fund finances a project “Leading Nanotechnologies” – a venture fund for low-budget projects financed the development of a new antiepileptic drug. The medicine will introduce a new mechanism of anticonvulsive action.

The issue becoming really topical, the drug will appear right on time: the population of the developed countries keeps aging while the number of registered incidents increases.

As of today, it’s the first time a fund created with the participation of RUSNANO financed a medical project.